Author

Hema Madhuri Mekala

Griffin Memorial Hospital - Cited by 1,010

Biography

Andhra Medical College NTR Class of 2011 OK State Medical License 2020 - 2022 Publications  Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients. Risks vs Benefits for SGLT2 Inhibitor Medications Does the Psychiatry Residency In-Training Examination (PRITE) Predict Performance on Initial Board Certification in Psychiatry?
Title
Cited by
Year
Focus on mental health during the coronavirus (COVID-19) pandemic: applying learnings from the past outbreaks
K Shah, D Kamrai, H Mekala, B Mann, K Desai, RS PatelCureus 12 (3), 2020202
529
2020
Traumatic brain injury and neuropsychiatric complications
S Ahmed, H Venigalla, HM Mekala, S Dar, M Hassan, S AyubIndian journal of psychological medicine 39 (2), 114-121, 2017201
160
2017
Post stroke depression frequently overlooked, undiagnosed, untreated
SK Dar, H Venigalla, AM Khan, R Ahmed, HM Mekala, H Zain, S ShaguftaNeuropsychiatry 7 (6), 906-919, 2017201
38
2017
Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: a comparative meta-analysis
S Ahmed, AM Khan, HM Mekala, H Venigalla, R Ahmed, A Etman, ...Heliyon 3 (11), 2017201
33
2017
Synthetic cannabinoids—” Spice” can induce a psychosis: A brief review
RR Yeruva, HM Mekala, M Sidhu, S LippmannInnovations in clinical neuroscience 16 (1-2), 31, 2019201
32
2019
An update on biomarkers in psychiatric disorders–are we aware, do we use in our clinical practice
H Venigalla, HM Mekala, M Hassan, R Ahmed, H Zain, S Dar, SS VelizMent Health Fam Med 13, 471-9, 2017201
26
2017
E-cigarette toxicity
G Tegin, HM Mekala, SK Sarai, S LippmannSouth Med J 111 (1), 35-38, 2018201
26
2018
Risks vs benefits for SGLT2 inhibitor medications
S Pittampalli, S Upadyayula, HM Mekala, S LippmannFederal Practitioner 35 (7), 45, 181
20
2018
Lithium suicide prevention: a brief review and reminder
SK Sarai, HM Mekala, S LippmannInnovations in clinical neuroscience 15 (11-12), 30, 2018201
19
2018
Cannabis use disorder and epilepsy: a cross‐national analysis of 657 072 hospitalized patients
RS Patel, HM Mekala, WE TankersleyThe American journal on addictions 28 (5), 353-360, 2019201
12
2019
Does vitamin D deficiency cause depression?
S Pittampalli, HM Mekala, S Upadhyayula, S LippmannThe primary care companion for CNS disorders 20 (5), 26263, 2018201
11
2018
Safety and efficacy of antipsychotics in pregnancy and lactation
YI Odhejo, A Jafri, HM Mekala, M Hassan, AM Khan, SK Dar, R AhmedJ Alcohol Drug Depend 5 (3), 267, 2017201
11
2017
Kratom: an emerging issue and need for regulations in the United States
K Shah, W Tankersley, H MekalaThe primary care companion for CNS disorders 23 (1), 26032, 2021202
9
2021
Cannabis-induced catatonia: a case series
H Mekala, Z Malik, J Lone, K Shah, M IshaqCureus 12 (6), 2020202
8
2020
Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility.
G Martz, W Tankersley, HM Mekala, H MotiwalaThe primary care companion for CNS disorders 20 (5), 2018201
7
2018
A 95-year-old man with treatment-resistant depression
P Narang, R Gandhi, T Sarkaria, HM Mekala, S LippmannCurrent Psychiatry 17 (1), 49, 01801
2
2018
Risk factors for illicit substance vaporizer use in adolescents
W Tankersley, G Martz, HM Mekala, H MotiwalaAddictive Disorders & Their Treatment 18 (1), -7, 01901
2
2019
Biomarkers in psychiatric disorders–a perspective
S Ahmed, RI Memon, H Venigalla, HM Mekala, O RamadanAnn Clin Case Rep 2, 289, 20720
1
2017
Dehydration in terminal illness: Which path forward?
K Brar, HM Mekala, S LippmannThe Journal of family practice 67 (0), E-E3, 20820
1
2018
Ketamine’s journey from sedation to suicide prevention: a viewpoint
S Ahmed, M Hassan, H VenigaliaJ Psychiatry 9, 383-384, 20620
1
2016

Referred From: https://scholar.google.com/citations?user=MxjrRvsAAAAJ&hl=en

Cited by
Citations 1010
h-index 12
i10-index 14
Recommended Journals
Open Access Journals